GO:1904692 positive regulation of type B pancreatic cell proliferation: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904692 describes any process that activates or increases the frequency, rate or extent of type B pancreatic cell (beta cell) proliferation [1,2].
• Beta cell proliferation is essential for maintaining functional beta cell mass and glucose homeostasis, and its failure contributes to diabetes [2,4].
• Key positive regulators include growth factors such as EGF, PDGF-AA, insulin/IGF signaling, and mTORC1, which drive cell cycle entry in beta cells [2,3,4,6].
• Developmental and pregnancy-related signals, including kisspeptin and serotonin, can also promote beta cell proliferation.
• Dysregulation of beta cell proliferation is linked to diabetes, and therapeutic strategies aim to enhance endogenous beta cell regeneration [6,8].
• CRISPR-based models (knockout, knock-in, overexpression) enable causal testing of candidate regulators of beta cell proliferation [1,3,5].
Description
The Gene Ontology term GO:1904692, positive regulation of type B pancreatic cell proliferation, refers to any biological process that activates or increases the frequency, rate or extent of the proliferation of pancreatic beta cells (type B pancreatic cells) [1,2]. Beta cells are the insulin-producing cells of the pancreatic islets, and their ability to proliferate is critical for maintaining adequate beta cell mass throughout life and in response to metabolic demand [2,4]. Understanding the positive regulation of beta cell proliferation is therefore central to diabetes research, as loss of beta cell mass or function leads to hyperglycemia [6,8]. This article synthesizes published findings on the signaling pathways, genes, and experimental models that define this GO term, providing a resource for researchers aiming to manipulate beta cell proliferation for therapeutic benefit.
positive regulation of type B pancreatic cell proliferation At A Glance
| GO ID | GO:1904692 |
|---|---|
| GO term | positive regulation of type B pancreatic cell proliferation |
| Ontology | biological_process |
| Synonym | activation of pancreatic beta cell proliferation; upregulation of pancreatic B cell proliferation; positive regulation of pancreatic beta cell proliferation |
| Major function | Stimulation of pancreatic beta cell division and expansion of beta cell mass |
| Related processes | Insulin signaling, growth factor signaling, mTORC1 pathway, cell cycle regulation |
| Key regulators | EGF, PDGF-AA, insulin/IGF-1, mTORC1, kisspeptin |
| Disease relevance | Diabetes mellitus, beta cell failure, pancreatic islet dysfunction |
What Is GO:1904692?
GO:1904692 is defined as any process that activates or increases the frequency, rate or extent of type B pancreatic cell proliferation. In simpler terms, it encompasses all molecular events and signaling cascades that stimulate pancreatic beta cells to divide and increase their numbers. This includes growth factor signaling, intracellular kinase cascades, and transcriptional programs that promote cell cycle progression in beta cells [2,3,4,6].
Why Is positive regulation of type B pancreatic cell proliferation Important in Cell Biology?
Positive regulation of type B pancreatic cell proliferation is fundamental for maintaining glucose homeostasis and adapting to increased insulin demand, such as during pregnancy or obesity [2,7]. Its dysregulation contributes to the pathogenesis of diabetes, where insufficient beta cell mass leads to chronic hyperglycemia [6,8]. Therefore, understanding the mechanisms that promote beta cell proliferation offers potential therapeutic avenues for diabetes treatment and beta cell regeneration [6,8].
• Maintains functional beta cell mass to meet insulin demand [2,4].
• Compensatory beta cell proliferation occurs during pregnancy and insulin resistance.
• Loss of beta cell proliferation contributes to type 1 and type 2 diabetes progression [6,8].
• Growth factor signaling (EGF, PDGF) directly stimulates beta cell proliferation [2,3].
• mTORC1 signaling is a critical node that integrates nutrient and growth signals to promote beta cell proliferation.
• Developmental regulators like FRK influence embryonic beta cell formation.
• Kisspeptin and serotonin pathways promote beta cell proliferation during pregnancy.
• Therapeutic strategies aim to enhance endogenous beta cell regeneration.
• CRISPR screening can identify novel positive regulators of beta cell proliferation [1,3,5].
• Beta cell proliferation is a key target for cell replacement therapies in diabetes [6,8].
What Happens During positive regulation of type B pancreatic cell proliferation?
Growth Factor Signaling Initiation
In simple terms: Growth factors act like keys that unlock beta cell division.
Positive regulation begins with extracellular growth factors such as EGF and PDGF-AA binding to their receptors on beta cells, triggering intracellular signaling cascades [2,3]. EGF receptor signaling has been shown to regulate beta cell mass, and bone-derived PDGF-AA promotes age-related beta cell proliferation [2,3].
Intracellular Kinase Cascade Activation
In simple terms: Inside the cell, a chain of molecular switches turns on the division program.
Following receptor activation, intracellular kinases including PI3K/Akt and mTORC1 are engaged. mTORC1 signaling is a double-edged sword in diabetic beta cells, but under normal conditions it promotes proliferation by driving protein synthesis and cell cycle progression. Insulin signaling also contributes to beta cell proliferation through autocrine/paracrine loops.
Cell Cycle Entry and Progression
In simple terms: The cell cycle engine starts, moving the beta cell toward division.
Activated signaling pathways induce expression of cyclins and CDKs, leading to retinoblastoma protein phosphorylation and E2F-mediated transcription of S-phase genes. This results in DNA replication and eventual mitosis. Positive regulators like ISL-1 may influence this process, although its role in beta cells is context-dependent.
Transcriptional and Epigenetic Regulation
In simple terms: Master switches in the nucleus turn genes on or off to sustain proliferation.
Transcription factors such as PDX1, FOXO1, and ISL-1 modulate the expression of genes involved in beta cell proliferation and survival [1,4]. Epigenetic modifications also contribute, but specific mechanisms in beta cells require further study.
Pregnancy and Hormonal Stimulation
In simple terms: Hormones during pregnancy can boost beta cell numbers.
Kisspeptin upregulates beta cell serotonin production during pregnancy, which in turn promotes beta cell proliferation to meet increased insulin demand. This highlights the physiological importance of positive regulation in reproductive states.
Key Genes Involved in GO:1904692 positive regulation of type B pancreatic cell proliferation
The following genes and proteins have been implicated in the positive regulation of type B pancreatic cell proliferation based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EGFR | Receptor for EGF; mediates growth factor signaling to promote beta cell proliferation | Target for modulating beta cell mass |
| PDGFA | Ligand for PDGF receptors; bone-derived PDGF-AA stimulates age-related beta cell proliferation | Potential therapeutic for age-related beta cell decline |
| INSR | Insulin receptor; mediates insulin signaling in beta cells | Autocrine regulation of beta cell function and proliferation |
| IRS1/2 | Insulin receptor substrates; downstream of insulin/IGF-1 signaling | Key nodes in beta cell proliferation pathways |
| MTOR | Kinase in mTORC1 complex; integrates nutrient and growth signals | Central regulator of beta cell proliferation and survival |
| RPTOR | Component of mTORC1; essential for mTORC1 activity | Genetic models to study mTORC1 in beta cells |
| ISL1 | Transcription factor; role in pancreatic development and beta cell function | Context-dependent effects on proliferation |
| FRK | Fyn-related kinase; involved in embryonal pancreatic beta cell formation | Developmental regulator of beta cell mass |
| KISS1 | Precursor of kisspeptin; upregulates serotonin production during pregnancy | Pregnancy-induced beta cell proliferation |
| TPH1 | Tryptophan hydroxylase 1; rate-limiting enzyme for serotonin synthesis | Mediates kisspeptin effects on beta cell proliferation |
| HTR2B | Serotonin receptor; mediates serotonin signaling in beta cells | Potential target for promoting beta cell proliferation |
| CCND1 | Cyclin D1; regulates G1/S transition in cell cycle | Downstream effector of proliferative signaling |
| CDK4 | Cyclin-dependent kinase 4; partners with cyclin D to drive cell cycle | Target for chemical inhibition in proliferation studies |
| FOXO1 | Transcription factor; integrates insulin signaling with cell cycle regulation | Modulates beta cell proliferation and survival |
| PDX1 | Homeodomain transcription factor; essential for beta cell identity and function | Master regulator of beta cell genes |
| IGF1 | Insulin-like growth factor 1; promotes beta cell proliferation and survival | Growth factor signaling in beta cells |
| GCG | Glucagon; can influence beta cell proliferation via paracrine effects | Islet hormone interplay |
How Is positive regulation of type B pancreatic cell proliferation Regulated?
Positive regulation of type B pancreatic cell proliferation is controlled by a network of signaling pathways. mTORC1 acts as a central hub, integrating nutrient and growth factor signals to promote protein synthesis and cell cycle progression. Insulin/IGF-1 signaling provides autocrine and endocrine cues that modulate beta cell proliferation. Growth factor receptors such as EGFR and PDGFR transmit external signals to intracellular kinases [2,3]. Hormonal signals, including kisspeptin and serotonin during pregnancy, also stimulate beta cell proliferation. Negative feedback mechanisms and context-dependent factors, such as ISL-1 in beta cells, fine-tune the proliferative response.
positive regulation of type B pancreatic cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MTOR | Diabetes mellitus; mTORC1 dysregulation in beta cells | Beta cell-specific mTOR knockout or knock-in mice |
| PDGFA | Age-related beta cell decline | PDGFA overexpression in bone or beta cells |
| KISS1 | Gestational diabetes; pregnancy-induced beta cell proliferation | Kisspeptin receptor knockout mice |
| INSR | Type 2 diabetes; insulin resistance | Beta cell-specific insulin receptor knockout |
| EGFR | Beta cell mass regulation; diabetes | EGFR dominant-negative or knockout models |
Diabetes Mellitus
Insufficient beta cell proliferation contributes to the loss of beta cell mass in both type 1 and type 2 diabetes. Therapies aimed at enhancing positive regulation of beta cell proliferation could restore functional beta cell mass [6,8]. mTORC1 signaling is dysregulated in diabetic beta cells, and its modulation may have therapeutic potential.
Age-Related Beta Cell Dysfunction
Aging is associated with reduced beta cell proliferation, and bone-derived PDGF-AA has been shown to promote age-related beta cell proliferation, suggesting a link between bone metabolism and beta cell homeostasis.
Gestational Diabetes
During pregnancy, beta cell proliferation increases to meet heightened insulin demand. Kisspeptin upregulates serotonin production, which promotes beta cell proliferation; failure of this adaptive response may contribute to gestational diabetes.
From positive regulation of type B pancreatic cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X promote beta cell proliferation? | CRISPR knockout in beta cell lines (e.g., INS-1, MIN6) [1,3] |
| Does a point mutation in gene Y affect beta cell proliferation? | CRISPR point mutation knock-in in primary beta cells or cell lines |
| Does overexpression of gene Z increase beta cell mass? | CRISPR activation or lentiviral overexpression in mouse islets [3,6] |
| What is the role of gene W in developmental beta cell formation? | CRISPR knockout in zebrafish or mouse embryos |
| Can a tagged version of protein V reveal its localization during proliferation? | CRISPR knock-in of fluorescent tag in beta cells |
| Which genes are essential for beta cell proliferation? | Genome-wide CRISPR library screening in beta cell lines [1,3,5] |
How to Study the positive regulation of type B pancreatic cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Loss-of-function effects on beta cell proliferation | Identify essential positive regulators [1,3] |
| RNA-seq | Transcriptional changes during proliferation | Discover upregulated pathways [4,6] |
| Phosphoproteomics | Kinase activity and signaling dynamics | Map mTORC1 and insulin signaling |
| EdU/BrdU incorporation | DNA synthesis as a marker of proliferation | Quantify beta cell proliferation in vitro and in vivo |
| Immunofluorescence | Protein localization and expression | Validate candidate regulators [1,3] |
| Flow cytometry | Cell cycle analysis and sorting | Isolate proliferating beta cells |
| Western blot | Protein expression and phosphorylation | Confirm signaling activation |
| qRT-PCR | mRNA levels of target genes | Validate RNA-seq findings |
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify novel positive regulators of beta cell proliferation. These screens use pooled lentiviral libraries to perturb thousands of genes and select for increased proliferation [1,3,5].
RNA Sequencing (RNA-seq)
RNA-seq measures transcriptomic changes in beta cells under conditions that promote proliferation, revealing upregulated pathways and candidate genes [4,6].
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics can quantify protein expression and phosphorylation changes in response to proliferative stimuli, identifying active signaling nodes.
Imaging and Lineage Tracing
Fluorescent reporters and lineage tracing in mouse models allow visualization of beta cell proliferation in vivo and tracking of cell division over time.
How CRISPR Can Be Used to Study GO:1904692 positive regulation of type B pancreatic cell proliferation
Knockout
CRISPR knockout of candidate genes in beta cell lines or primary islets can determine whether a gene is required for beta cell proliferation. For example, knocking out mTOR or EGFR reduces proliferative capacity [2,6].
Point Mutation
CRISPR point mutation knock-in can model disease-associated variants or phospho-dead mutants to dissect signaling mechanisms. This approach is useful for studying genes like PDGFA or INSR [3,4].
Knock-in
Knock-in of reporter genes (e.g., fluorescent proteins) or epitope tags allows visualization and tracking of endogenous proteins during beta cell proliferation.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can test whether increasing a gene's activity is sufficient to drive beta cell proliferation. Overexpression of PDGF-AA or constitutively active mTORC1 promotes proliferation [3,6].
How EDITGENE Supports positive regulation of type B pancreatic cell proliferation Research
Researchers studying positive regulation of type B pancreatic cell proliferation-related genes often need to determine whether a candidate gene is causally involved in driving beta cell division. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of type B pancreatic cell proliferation research.
Frequently Asked Questions About positive regulation of type B pancreatic cell proliferation
What is GO:1904692?
GO:1904692 is a Gene Ontology term for any process that activates or increases the frequency, rate or extent of type B pancreatic cell (beta cell) proliferation [1,2].
What genes are involved in positive regulation of type B pancreatic cell proliferation?
Key genes include EGFR, PDGFA, INSR, MTOR, ISL1, FRK, KISS1, and CCND1, among others [1,2,3,4,5,6,7].
How is beta cell proliferation regulated?
It is regulated by growth factors (EGF, PDGF), insulin/IGF-1 signaling, mTORC1, and hormonal cues such as kisspeptin and serotonin [2,3,4,6,7].
Why is beta cell proliferation important in diabetes?
Loss of beta cell mass due to insufficient proliferation contributes to hyperglycemia in diabetes; enhancing proliferation is a therapeutic goal [6,8].
What experimental models are used to study beta cell proliferation?
Common models include CRISPR knockout/knock-in in beta cell lines, mouse genetics, and primary islet cultures [1,3,5,6].
Can CRISPR be used to study positive regulators of beta cell proliferation?
Yes, CRISPR knockout, activation, and screening are powerful tools to identify and validate regulators [1,3,5].
What is the role of mTORC1 in beta cell proliferation?
mTORC1 integrates nutrient and growth signals to promote protein synthesis and cell cycle progression, but its chronic activation can be detrimental.
How does pregnancy affect beta cell proliferation?
Pregnancy induces beta cell proliferation via hormonal signals including kisspeptin and serotonin to meet increased insulin demand.
What is the relationship between PDGF-AA and beta cell proliferation?
Bone-derived PDGF-AA promotes age-related beta cell proliferation, linking bone metabolism to beta cell homeostasis.
What services does EDITGENE offer for beta cell research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services [1,3,5].
Conclusion
GO:1904692, positive regulation of type B pancreatic cell proliferation, encompasses critical signaling pathways that drive beta cell division. Understanding these mechanisms is essential for developing therapies to restore beta cell mass in diabetes. CRISPR-based tools and models continue to advance this field, offering hope for regenerative medicine approaches [6,8].
References
- 1. Zhang Q et al.. 2014. A positive feedback regulation of ISL-1 in DLBCL but not in pancreatic β-cells.. Biochem Biophys Res Commun 449(3):295-300 PMID: 24845569
- 2. Miettinen P et al.. 2008. EGF receptor in pancreatic beta-cell mass regulation.. Biochem Soc Trans 36(Pt 3):280-5 PMID: 18481942
- 3. Liu X et al.. 2020. The role of bone-derived PDGF-AA in age-related pancreatic β cell proliferation and function.. Biochem Biophys Res Commun 524(1):22-27 PMID: 31980171
- 4. Leibiger IB et al.. 2008. Insulin signaling in the pancreatic beta-cell.. Annu Rev Nutr 28:233-51 PMID: 18481923
- 5. Akerblom B et al.. 2007. A role of FRK in regulation of embryonal pancreatic beta cell formation.. Mol Cell Endocrinol 270(1-2):73-8 PMID: 17416457
- 6. Ardestani A et al.. 2018. mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells.. Cell Metab 27(2):314-331 PMID: 29275961
- 7. Hill TG et al.. 2024. Kisspeptin upregulates β-cell serotonin production during pregnancy.. J Endocrinol 260(2) PMID: 37997938
- 8. Juhl K et al.. 2010. Regenerating pancreatic beta-cells: plasticity of adult pancreatic cells and the feasibility of in-vivo neogenesis.. Curr Opin Organ Transplant 15(1):79-85 PMID: 19907327
